Severity
Moderate
FDA Devices recall · Reported April 28, 2021
Inability for the user to inject the paste from the syringe into the target location.
Stryker Leibinger GmbH & Co. Kg recalled DirectInject consists of a sterile dual paste system which is calcium phosphate based. Up… - a moderate-severity action.
DirectInject consists of a sterile dual paste system which is calcium phosphate based. Up… was recalled by Stryker Leibinger GmbH & Co. Kg in April 28, 2021. Reason: Inability for the user to inject the paste from the syringe into the target location.. Check the official notice for the remedy. Verify recall #Z-1436-2021 with the FDA Devices before acting.
The recall
Stryker Leibinger GmbH & Co. Kg issued this moderate-severity FDA Devices recall-Inability for the user to inject the paste from the syringe into the target location..
Sourced from official FDA Devices enforcement records. Verify recall #Z-1436-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1436-2021) was formally reported on April 28, 2021, with the manufacturer initiating the action on April 1, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Stryker Leibinger GmbH & Co. Kg is listed as the recalling firm, operating out of Freiburg Im Breisgau, N/A. Federal records list the affected scope as 321 units.
The documented reason for this recall is: Inability for the user to inject the paste from the syringe into the target location. Distribution data in the federal record shows the product reached: Worldwide distribution - US Nationwide distribution and the countries of Germany, Italy, France, Australia, Japan.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
321 units
Related Recalls
6
3 from same agency
DirectInject consists of a sterile dual paste system which is calcium phosphate based. Upon injection through the Mixer-Cannula, the two pastes form a cement paste which is moldable. The injected cement paste will harden under normal body conditions to form hydroxyapatite.
Inability for the user to inject the paste from the syringe into the target location.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1436-2021 |
| Date reported | April 28, 2021 |
| Date initiated | April 1, 2021 |
| Recalling firm | Stryker Leibinger GmbH & Co. Kg |
| Firm location | Freiburg Im Breisgau, N/A |
| Affected scope | 321 units |
| Distribution | Worldwide distribution - US Nationwide distribution and the countries of Germany, Italy, France, Australia, Japan. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported April 28, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.